| Date | Title | Description |
| 20.09.2024 | Navigating the Warrant Landscape: A Look at Brain+ and Diagonal Bio | In the world of finance, warrants are like keys to a treasure chest. They offer investors the chance to unlock new shares at a predetermined price. Recently, two companies, Brain+ A/S and Diagonal Bio AB, have made headlines with their warr... |
| 19.09.2024 | The last day of trading in warrants of series TO 1 is on the 24th of September 2024 | The last day of trading in warrants of series TO 1 is on the 24th of September 2024
Thu, Sep 19, 2024 08:30 CET Report this content Read original
The 24th of September 2024 is the last day of trading in warrants of series TO 1, which were i... |
| 14.09.2024 | Curasight and Brain+: Navigating the Waters of Rights Issues and Warrants | In the bustling world of biotech, companies often seek new avenues for funding. Two Danish firms, Curasight A/S and Brain+ A/S, recently made headlines with their respective rights issues and warrant exercises. These financial maneuvers are... |
| 12.09.2024 | The exercise period for warrants of series TO 1 commences today | The exercise period for warrants of series TO 1 commences today
Thu, Sep 12, 2024 08:30 CET Report this content Read original
Today is the first day for the exercise of Diagonal Bio AB's ("Diagonal Bio" or "the Company")... |
| 12.09.2024 | The exercise period for warrants of series TO 4 commences today | The exercise period for warrants of series TO 4 commences today
Thu, Sep 12, 2024 08:55 CET Report this content
Today is the first day for the exercise of Phase Holographic Imaging PHI AB's ("PHI" or "Company") warrants ... |
| 12.09.2024 | Curasight A/S publishes prospectus due to upcoming rights issue | Curasight A/S publishes prospectus due to upcoming rights issue
Thu, Sep 12, 2024 12:22 CET Report this content
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, C... |
| 11.09.2024 | Navigating the Warrant Landscape: A Look at Diagonal Bio and PHI | In the world of biotechnology, warrants can be a double-edged sword. They offer potential, but they also come with risks. Recently, two companies, Diagonal Bio AB and Phase Holographic Imaging (PHI) AB, announced the exercise prices for the... |
| 11.09.2024 | The exercise price for warrants of series TO 4 has been set to SEK 4.63 per new share | The exercise price for warrants of series TO 4 has been set to SEK 4.63 per new share
Wed, Sep 11, 2024 09:36 CET Report this content
Phase Holographic Imaging PHI AB ("PHI" or "the Company") hereby announces that the ex... |
| 11.09.2024 | The exercise price for warrants of series TO 1 has been set to SEK 0,05 per new share | The exercise price for warrants of series TO 1 has been set to SEK 0,05 per new share
Wed, Sep 11, 2024 09:00 CET Report this content Read original
Diagonal Bio AB ("Diagonal Bio" or "the Company") hereby announces that ... |
| 24.06.2024 | Brain+ obtains additional guarantee commitment in its ongoing rights issue | Brain+ obtains additional guarantee commitment in its ongoing rights issue
Mon, Jun 24, 2024 10:06 CET Report this content
Copenhagen, Denmark, 24 June 2024 – Brain+ A/S (Nasdaq First North: BRAINP)
Brain+ A/S (“Brain+” or the “Company”) an... |
| 21.06.2024 | Last day for subscription in the ongoing rights issue | Last day for subscription in the ongoing rights issue
Fri, Jun 21, 2024 08:45 CET Report this content
Copenhagen, Denmark, 21 June, 2024 – Brain+ A/S (Nasdaq First North: BRAINP)
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR IND... |
| 20.06.2024 | Brain+ receives guarantee commitment from health tech specialized German investment boutique and additional subscription from management in its ongoing rights issue | Brain+ receives guarantee commitment from health tech specialized German investment boutique and additional subscription from management in its ongoing rights issue
Thu, Jun 20, 2024 12:37 CET Report this content
Copenhagen, Denmark, 20 Jun... |
| 20.06.2024 | Clinical Laserthermia Systems publishes supplementary prospectus regarding ongoing rights issue | Clinical Laserthermia Systems publishes supplementary prospectus regarding ongoing rights issue
Thu, Jun 20, 2024 14:00 CET Report this content
Clinical Laserthermia Systems AB (publ) (“CLS” or the ”Company”) has drafted a supplementary pro... |
| 20.06.2024 | Correction - Brain+ receives guarantee commitment from health tech specialized German investment boutique and additional subscription from management in its ongoing rights issue | Correction - Brain+ receives guarantee commitment from health tech specialized German investment boutique and additional subscription from management in its ongoing rights issue
Thu, Jun 20, 2024 13:50 CET Report this content
The company an... |
| 13.06.2024 | The last day of trading in warrants of series TO 3 is on the 17th of June 2024 | The last day of trading in warrants of series TO 3 is on the 17th of June 2024
Thu, Jun 13, 2024 08:45 CET Report this content
The 17th of June 2024 is the last day of trading in warrants of series TO 3, which were issued in connection with... |
| 11.06.2024 | DanCann Pharma A/S: The subscription period of DanCann Pharma’s Rights Issue begins today | DanCann Pharma A/S: The subscription period of DanCann Pharma’s Rights Issue begins today
Tue, Jun 11, 2024 08:00 CET Report this content
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, WITHIN OR TO... |
| 11.06.2024 | The subscription period in Brain+ unit rights issue begins today | The subscription period in Brain+ unit rights issue begins today
Tue, Jun 11, 2024 08:47 CET Report this content
Copenhagen, Denmark, 11 June 2024 – Brain+ A/S (Nasdaq First North: BRAINP)
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIREC... |
| 10.06.2024 | CLS publishes prospectus in connection with forthcoming rights issue | CLS publishes prospectus in connection with forthcoming rights issue
Mon, Jun 10, 2024 17:00 CET Report this content
THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES O... |
| 05.06.2024 | The exercise period for warrants of series TO 3 commences today | The exercise period for warrants of series TO 3 commences today
Wed, Jun 05, 2024 08:30 CET Report this content
Today is the first day for the exercise of Carbiotix AB's ("Carbiotix" or "Company") warrants of series TO 3... |
| 04.06.2024 | Brain+ A/S informs of the last day of trading in its shares including preferential rights to subscribe in the upcoming unit rights issue | Brain+ A/S informs of the last day of trading in its shares including preferential rights to subscribe in the upcoming unit rights issue
Tue, Jun 04, 2024 08:30 CET Report this content
Copenhagen, Denmark, 4 June 2024 – Brain+ A/S (Nasdaq F... |
| 03.06.2024 | The exercise price for warrants of series TO 3 has been set to SEK 0.04 per new share | The exercise price for warrants of series TO 3 has been set to SEK 0.04 per new share
Mon, Jun 03, 2024 19:00 CET Report this content
Carbiotix AB ("Carbiotix" or "the Company") hereby announces that the exercise price f... |
| 31.05.2024 | Brain+ A/S: Publication of investment brochure | Brain+ A/S: Publication of investment brochure
Fri, May 31, 2024 13:59 CET Report this content
Copenhagen, Denmark, 31 May 2024 – Brain+ A/S (Nasdaq First North: BRAINP)
The Board of Directors of Brain+ A/S (“Brain+” or the “Company”) decid... |
| 30.05.2024 | CLS resolves on a partially guaranteed Rights Issue of approximately SEK 59m | CLS resolves on a partially guaranteed Rights Issue of approximately SEK 59m
Thu, May 30, 2024 18:20 CET Report this content
THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED ... |
| 07.05.2024 | Brain+ A/S announce a partially secured rights issue of units of approximately DKK 8.94 million to fund operations and execution of its UK commercialization plan | Brain+ A/S announce a partially secured rights issue of units of approximately DKK 8.94 million to fund operations and execution of its UK commercialization plan
Tue, May 07, 2024 08:52 CET Report this content
Copenhagen, Denmark, 7 May 202... |
| 23.04.2024 | BoMill publishes prospectus regarding the Rights Issue | BoMill publishes prospectus regarding the Rights Issue
Tue, Apr 23, 2024 16:44 CET Report this content
THIS PRESS RELEASE IS NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, WITHIN OR INTO AUSTRALIA, BELARUS, CANADA, HO... |
| 17.04.2024 | Last day for trading in BoMill's shares including the right to participate in the share issue | Last day for trading in BoMill's shares including the right to participate in the share issue
Wed, Apr 17, 2024 08:30 CET Report this content
THIS PRESS RELEASE IS NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, WITHIN... |
| 12.04.2024 | Communiqué from Annual General Meeting in BoMill AB | Communiqué from Annual General Meeting in BoMill AB
Fri, Apr 12, 2024 10:58 CET Report this content
THIS PRESS RELEASE IS NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, WITHIN OR INTO AUSTRALIA, BELARUS, CANADA, HONG ... |
| 08.04.2024 | The subscription period in Diagonal Bio AB rights issue commences today | The subscription period in Diagonal Bio AB rights issue commences today
Mon, Apr 08, 2024 08:00 CET Report this content
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES, AUSTRALIA, HONG KONG, ... |
| 03.04.2024 | Diagonal Bio AB publishes a prospectus because of upcoming rights issue | Diagonal Bio AB publishes a prospectus because of upcoming rights issue
Wed, Apr 03, 2024 18:00 CET Report this content
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES, AUSTRALIA, HONG KONG, ... |
| 12.03.2024 | BoMill Board of Directors proposes a secured new share issue of maximum SEK 16.8 million to take the next step in further scaling up the commercialization of BoMill InSight | BoMill Board of Directors proposes a secured new share issue of maximum SEK 16.8 million to take the next step in further scaling up the commercialization of BoMill InSight
Tue, Mar 12, 2024 08:30 CET Report this content
THIS PRESS RELEASE ... |
| 19.02.2024 | Per Lindberg BidCo AB makes public the Offer Document regarding the mandatory bid for Ranplan Group AB | Per Lindberg BidCo AB makes public the Offer Document regarding the mandatory bid for Ranplan Group AB
Mon, Feb 19, 2024 18:52 CET Report this content
2024-02-19
NOTE: The Swedish version of this press release takes precedence over any othe... |
| 30.10.2023 | The subscription period in Crunchfish's rights issue ends on November 1st, 2023 | The subscription period in Crunchfish's rights issue ends on November 1st, 2023
Mon, Oct 30, 2023 08:30 CET Report this content
The last day to subscribe for shares in Crunchfish AB's ("Crunchfish" or the "Company") righ... |
| 18.10.2023 | The subscription period in Crunchfish’s rights issue begins today | The subscription period in Crunchfish’s rights issue begins today
Wed, Oct 18, 2023 08:30 CET Report this content
Today, October 18, 2023, the subscription period in Crunchfish AB’s (“Crunchfish” or the “Company”) rights issue of approximat... |
| 21.09.2023 | Last day for subscription in the ongoing rights issue | Last day for subscription in the ongoing rights issue
Thu, Sep 21, 2023 08:45 CET Report this content
THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, HONG KONG, JAPAN, CANAD... |
| 12.09.2023 | The subscription period in the rights issue begins today | The subscription period in the rights issue begins today
Tue, Sep 12, 2023 08:45 CET Report this content
THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, HONG KONG, JAPAN, CA... |
| 08.09.2023 | Clean Industry Solutions Holding Europe AB (publ) publishes prospectus in connection with the rights issue | Clean Industry Solutions Holding Europe AB (publ) publishes prospectus in connection with the rights issue
Fri, Sep 08, 2023 15:00 CET Report this content
THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDI... |
| 26.07.2023 | Cline Scientific: Cline has reached the minimum limit in the ongoing rights issue | Cline Scientific: Cline has reached the minimum limit in the ongoing rights issue
Wed, Jul 26, 2023 14:27 CET Report this content
The board of Cline Scientific AB can today state that the minimum limit in the ongoing rights issue of SEK 5.5... |
| 14.07.2023 | The current subscription period is extended to July 17 | The current subscription period is extended to July 17
Fri, Jul 14, 2023 08:42 CET Report this content
The Board of Cline Scientific AB has decided to extend the subscription period in the ongoing rights issue. The extension applies until M... |
| 11.07.2023 | Cline Scientific: The new issue closes on July 12 | Cline Scientific: The new issue closes on July 12
Tue, Jul 11, 2023 14:37 CET Report this content
Cline Scientific AB's Rights Issue closes tomorrow, July 12. The rights issue gives existing shareholders the right to subscribe for two new s... |
| 26.06.2023 | Cline Scientific: Cline Scientific AB's rights issue begins today | Cline Scientific: Cline Scientific AB's rights issue begins today
Mon, Jun 26, 2023 08:30 CET Report this content
Today begins the rights issue in Cline Scientific AB. The issue is carried out on terms of 2:1, which means that for each exis... |
| 22.06.2023 | Cline Scientific: Cline Scientific AB publishes memorandum regarding the Rights Issue | Cline Scientific: Cline Scientific AB publishes memorandum regarding the Rights Issue
Thu, Jun 22, 2023 08:36 CET Report this content
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRA... |
| 20.06.2023 | OmniCar Holding AB publishes issuing memorandum regarding the upcoming rights issue | OmniCar Holding AB publishes issuing memorandum regarding the upcoming rights issue
Tue, Jun 20, 2023 14:01 CET Report this content
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES OR ANY JURIS... |
| 19.06.2023 | Correction: Realheart Publishes Prospectus in Connection With Rights Issue of Units of Approximately SEK 56 Million | Correction: Realheart Publishes Prospectus in Connection With Rights Issue of Units of Approximately SEK 56 Million
Mon, Jun 19, 2023 08:52 CET Report this content
Press Release, 19 June 2023
The previous press release was inadvertently pub... |
| 19.06.2023 | Realheart Publishes Prospectus in Connection With Rights Issue of Units of Approximately SEK 56 Million | Realheart Publishes Prospectus in Connection With Rights Issue of Units of Approximately SEK 56 Million
Mon, Jun 19, 2023 08:30 CET Report this content
Press Release 19 June, 2023
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN ... |
| 12.06.2023 | Cline Scientific: Cline decides on a share issue | Cline Scientific: Cline decides on a share issue
Mon, Jun 12, 2023 08:30 CET Report this content
INFORMATION IN THIS PRESS RELEASE MAY NOT BE PUBLISHED, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES, AUSTRALIA... |
| 26.05.2023 | DanCann Pharma A/S has secured 71 percent of the TO 2’s | DanCann Pharma A/S has secured 71 percent of the TO 2’s
Fri, May 26, 2023 08:30 CET Report this content
COPENHAGEN, Denmark, 26 May 2023 - DanCann Pharma A/S (SS: DANCAN) (OTCQB: DCPXF) ("DanCann Pharma" or the "Company"... |
| 16.05.2023 | DanCann Pharma A/S: The exercise period for warrants of series TO 2 begins today | DanCann Pharma A/S: The exercise period for warrants of series TO 2 begins today
Tue, May 16, 2023 09:00 CET Report this content
COPENHAGEN, Denmark, 16 May 2023 - DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the "Com... |
| 15.05.2023 | DanCann Pharma A/S: The subscription price for warrants of series TO 2 has been set | DanCann Pharma A/S: The subscription price for warrants of series TO 2 has been set
Mon, May 15, 2023 17:00 CET Report this content
COPENHAGEN, Denmark, 15 May 2023 - DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the "... |
| 19.04.2023 | Sista dagen av teckningsperioden i GomSpace företrädesemission | Sista dagen av teckningsperioden i GomSpace företrädesemission
Wed, Apr 19, 2023 12:40 CET Report this content
Idag den 19 april 2023 är sista dagen av teckningsperioden i GomSpace Group AB:s (publ) (”GomSpace” eller ”Bolaget”) företrädesem... |
| 19.04.2023 | The subscription period in BoMill’s rights issue begins today | The subscription period in BoMill’s rights issue begins today
Wed, Apr 19, 2023 09:15 CET Report this content
Today, April 19, 2023, the subscription period commences in BoMill AB’s (“BoMill” or the “Company”) rights issue of a maximum of 4... |
| 19.04.2023 | The last day of the subscription period in GomSpace’s rights issue | The last day of the subscription period in GomSpace’s rights issue
Wed, Apr 19, 2023 12:40 CET Report this content
Today, 19 April 2023, is the last day of the subscription period in GomSpace Group AB's (publ) ("GomSpace" or the &... |
| 17.04.2023 | Cline Scientific: Cline is carrying out a new share issue | Cline Scientific: Cline is carrying out a new share issue
Mon, Apr 17, 2023 13:15 CET Report this content
The board of Cline Scientific AB (“Cline” or “The Company”) has, with the support of the authorization from the annual general meeting... |
| 12.04.2023 | BoMill publishes prospectus regarding the rights issue | BoMill publishes prospectus regarding the rights issue
Wed, Apr 12, 2023 16:49 CET Report this content
Today BoMill AB (”BoMill” or the “Company”) has published a prospectus regarding the preferential rights issue of shares resolved by the ... |
| 29.03.2023 | Stayble Therapeutics AB publishes supplementary prospectus regarding the rights issue | Stayble Therapeutics AB publishes supplementary prospectus regarding the rights issue
Wed, Mar 29, 2023 13:25 CET Report this content
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRA... |
| 28.03.2023 | StaybIe Therapeutics AB receives additional underwriting commitments for the ongoing rights issue | StaybIe Therapeutics AB receives additional underwriting commitments for the ongoing rights issue
Tue, Mar 28, 2023 17:40 CET Report this content
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED ST... |
| 24.03.2023 | Today the subscription period of StaybIe Therapeutics AB’s rights issue starts | Today the subscription period of StaybIe Therapeutics AB’s rights issue starts
Fri, Mar 24, 2023 09:30 CET Report this content
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, JA... |
| 23.03.2023 | StaybIe Therapeutics AB receives additional pre-subscription and underwriting commitments for the upcoming rights issue | StaybIe Therapeutics AB receives additional pre-subscription and underwriting commitments for the upcoming rights issue
Thu, Mar 23, 2023 21:30 CET Report this content
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN... |
| 22.02.2023 | REMINDER: HEART TO1 Redemption Period Coming to an end | REMINDER: HEART TO1 Redemption Period Coming to an end
Wed, Feb 22, 2023 08:30 CET Report this content
Press Release 22 February, 2023
February 24 is the last day for trading in warrants of series TO1 in Scandinavian Real Heart AB ("Re... |
| 17.02.2023 | MEEW A/S RECEIVES APPROVAL FOR LISTING ON SPOTLIGHT STOCK MARKET AND PUBLISHES MEMORANDUM | MEEW A/S RECEIVES APPROVAL FOR LISTING ON SPOTLIGHT STOCK MARKET AND PUBLISHES MEMORANDUM
Fri, Feb 17, 2023 17:39 CET Report this content
MeeW A/S (“MeeW” or the “Company”) hereby announces that Spotlight Stock Market has given its approval... |
| 31.01.2023 | Correction: the Subscription Price for Realhearts Warrant TO1 is SEK 2.36 | Correction: the Subscription Price for Realhearts Warrant TO1 is SEK 2.36
Tue, Jan 31, 2023 10:49 CET Report this content
Press Release 31 January, 2023
Scandinavian Realheart AB ("Realheart" or the "Company"), issued du... |
| 30.01.2023 | Information on Trading and Exercise of Warrants of Series TO1 in Realheart | Information on Trading and Exercise of Warrants of Series TO1 in Realheart
Mon, Jan 30, 2023 17:09 CET Report this content
Press Release 30 January, 2023
Scandinavian Realheart AB ("Realheart" or the "Company"), issued d... |
| 05.12.2022 | The exercise period for Crunchfish’s warrants of series TO9 commences today | The exercise period for Crunchfish’s warrants of series TO9 commences today
Mon, Dec 05, 2022 08:30 CET Report this content
Crunchfish AB (“Crunchfish” or the “Company”) conducted a unit issue of shares and warrants of series TO9 in October... |
| 25.11.2022 | Safeture AB meddelar sista dag för handel med BTA | Safeture AB meddelar sista dag för handel med BTA
Fri, Nov 25, 2022 09:51 CET Report this content
Safeture AB:s, org. nr. 556776-4674, (”Safeture” eller ”Bolaget”), företrädesemission av aktier, vars teckningsperiod avslutades den 11 novemb... |
| 15.11.2022 | Safeture AB:s företrädesemission övertecknad | Safeture AB:s företrädesemission övertecknad
Tue, Nov 15, 2022 11:30 CET Report this content
Teckningsperioden i Safeture AB:s (publ) (”Safeture” eller ”Bolaget”) företrädesemission av aktier, i vilken även allmänheten gavs möjlighet att te... |
| 31.10.2022 | DanCann Pharma A/S: The subscription period in DanCann Pharma’s Rights Issue begins today | DanCann Pharma A/S: The subscription period in DanCann Pharma’s Rights Issue begins today
Mon, Oct 31, 2022 08:45 CET Report this content
COPENHAGEN, Denmark, October 31, 2022 - DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or... |
| 07.09.2022 | CS MEDICA A/S warrant exercise registered with the Danish Companies Registration Office | CS MEDICA A/S warrant exercise registered with the Danish Companies Registration Office
Wed, Sep 07, 2022 19:02 CET Report this content
On Thursday, 1 September 2022, the exercise period for CS MEDICA A/S (“CS MEDICA” or the “Company”) warr... |
| 06.09.2022 | CS MEDICA A/S raises approx. DKK 9.9 million through warrant exercise | CS MEDICA A/S raises approx. DKK 9.9 million through warrant exercise
Tue, Sep 06, 2022 08:45 CET Report this content
During the period 18 August 2022 – 1 September 2022, holders of warrants of series TO 1 have been entitled to subscribe fo... |
| 26.08.2022 | Last day of trading in warrants of series TO 1 is 30 August 2022 | Last day of trading in warrants of series TO 1 is 30 August 2022
Fri, Aug 26, 2022 08:00 CET Report this content
Tuesday, 30 August 2022, is the last day of trading in CS MEDICA A/S’s (“CS MEDICA” or the “Company”) warrants of series TO 1 o... |
| 23.08.2022 | The subscription period in Clinical Laserthermia Systems AB’s (publ) rights issue begins today | The subscription period in Clinical Laserthermia Systems AB’s (publ) rights issue begins today
Tue, Aug 23, 2022 08:30 CET Report this content
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STAT... |
| 18.08.2022 | The exercise period for warrants of series TO 1 begins today | The exercise period for warrants of series TO 1 begins today
Thu, Aug 18, 2022 09:00 CET Report this content
Today, 18 August 2022, marks the beginning of the exercise period for warrants of series TO 1, that were issued in connection with ... |
| 16.08.2022 | Clinical Laserthermia Systems AB (publ) publishes prospectus relating to the rights issue | Clinical Laserthermia Systems AB (publ) publishes prospectus relating to the rights issue
Tue, Aug 16, 2022 16:55 CET Report this content
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF... |
| 27.05.2022 | Loyal Solutions announces the outcome of the exercise of warrants of series TO 1 | Loyal Solutions announces the outcome of the exercise of warrants of series TO 1
Fri, May 27, 2022 19:11 CET Report this content
On Wednesday, 25 May 2022, the exercise period for Loyal Solutions A/S (“Loyal Solutions” or the “Company”) war... |
| 20.05.2022 | Last day of trading in warrants of series TO 1 is 23 May 2022 | Last day of trading in warrants of series TO 1 is 23 May 2022
Fri, May 20, 2022 09:14 CET Report this content
Monday, 23 May 2022, is the last day of trading in Loyal Solutions A/S’s (“Loyal Solutions” or the “Company”) warrants of series T... |
| 04.05.2022 | The exercise period for warrants of series TO 1 begins today | The exercise period for warrants of series TO 1 begins today
Wed, May 04, 2022 09:04 CET Report this content
Today, 4 May 2022, marks the beginning of the exercise period for the warrants of series TO 1 in Loyal Solutions A/S (“Loyal Soluti... |
| 26.04.2022 | BoMill publishes information memorandum regarding the Rights Issue | BoMill publishes information memorandum regarding the Rights Issue
Tue, Apr 26, 2022 08:00 CET Report this content
BoMill AB (publ) (”BoMill” or the “Company”) today publishes an information memorandum by reason of the proposed preferential... |
| 20.04.2022 | Today, trade commences in the Katalysen Ventures AB (publ) share on Spotlight Stock Market | Today, trade commences in the Katalysen Ventures AB (publ) share on Spotlight Stock Market
Wed, Apr 20, 2022 12:38 CET Report this content
Today, trade commences in the Katalysen Ventures AB (publ) (“Katalysen” or “the Company”) share on Sp... |
| 12.04.2022 | Katalysen Ventures AB (publ) announces oversubscribed listing issue | Katalysen Ventures AB (publ) announces oversubscribed listing issue
Tue, Apr 12, 2022 16:20 CET Report this content
On April 10, 2022, the subscription period in Katalysen Ventures AB's (publ) ("Katalysen" or "the Company&quo... |
| 06.04.2022 | Katalysen Ventures AB (publ) publishes supplementary memorandum as a result of signed subscription commitments in ongoing listing issue | Katalysen Ventures AB (publ) publishes supplementary memorandum as a result of signed subscription commitments in ongoing listing issue
Wed, Apr 06, 2022 08:59 CET Report this content
Katalysen Ventures AB (publ) ("Katalysen" or &... |
| 05.04.2022 | Katalysen Ventures AB (publ) signs subscription commitments in ongoing listing issue | Katalysen Ventures AB (publ) signs subscription commitments in ongoing listing issue
Tue, Apr 05, 2022 11:09 CET Report this content
Katalysen Ventures AB (publ) (“Katalysen” or “the Company”) hereby announces that the Company has signed su... |
| 04.04.2022 | Katalysen Ventures AB (publ) publishes supplementary memorandum as a result of new cooperation agreement | Katalysen Ventures AB (publ) publishes supplementary memorandum as a result of new cooperation agreement
Mon, Apr 04, 2022 16:29 CET Report this content
Katalysen Ventures AB (publ) ("Katalysen" or "the Company") hereby ... |
| 01.04.2022 | SynAct publishes prospectus in connection with a fully guaranteed rights issue | SynAct publishes prospectus in connection with a fully guaranteed rights issue
Fri, Apr 01, 2022 14:59 CET Report this content
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, A... |
| 29.03.2022 | ANNOUNCING REDUCED TRANSACTION COST IN RELATION TO IPO OFFER | ANNOUNCING REDUCED TRANSACTION COST IN RELATION TO IPO OFFER
Tue, Mar 29, 2022 17:50 CET Report this content
On 24 March 2022, Katalysen Ventures AB (publ)’s investment memorandum was approved by Spotlight Stock Market. In this investment m... |
| 28.03.2022 | SynAct resolves on a fully guaranteed rights issue of approximately SEK 150 million | SynAct resolves on a fully guaranteed rights issue of approximately SEK 150 million
Mon, Mar 28, 2022 07:00 CET Report this content
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERI... |
| 25.03.2022 | The subscription period in Katalysen Ventures AB (publ) share issue starts today | The subscription period in Katalysen Ventures AB (publ) share issue starts today
Fri, Mar 25, 2022 08:50 CET Report this content
Today, 25 March 2022, is the first day of the subscription period in Katalysen Ventures AB (publ)’s (”Katalysen... |
| 24.03.2022 | Katalysen Ventures AB (publ) receives approval for listing and publishes memorandum | Katalysen Ventures AB (publ) receives approval for listing and publishes memorandum
Thu, Mar 24, 2022 10:13 CET Report this content
Katalysen Ventures AB (publ) (“Katalysen” or the ”Company”) hereby announces that the Company has been appro... |
| 17.03.2022 | Today Is The Last Day Of The Subscription Period In Bawat Water Technologies AB | Today Is The Last Day Of The Subscription Period In Bawat Water Technologies AB
Thu, Mar 17, 2022 10:17 CET Report this content
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, WITHIN OR TO THE UNITE... |
| 23.02.2022 | Flat Capital offentliggör prospekt i samband med företrädesemission om cirka 190 MSEK och bjuder in till digital aktieägarträff den 8 mars | Offentliggörande av Prospektet
För fullständig information om företrädesemissionen hänvisas till det Prospekt som har upprättats och idag har godkänts av Finansinspektionen. Prospektet finns tillgängligt på Bolagets hemsida, Augment Partner... |
| 22.12.2021 | Cessatech successfully raises approx. DKK 24.3 million through warrant exercise and does not activate guarantee commitments | During the period 25 November - 16 December 2021, holders of TO 1 have been entitled to subscribe for shares with warrants. A total of 2,432,535 warrants were exercised, corresponding to 2,432,535 shares and an overall exercise rate of appr... |
| 22.12.2021 | Cessatech successfully raises approx. DKK 24.3 million through warrant exercise and does not activate guarantee commitments | Cessatech successfully raises approx. DKK 24.3 million through warrant exercise and does not activate guarantee commitments Wed, Dec 22, 2021 13:07 CET
During the period 25 November – 16 December 2021, holders of TO 1 have been entitled to ... |
| 14.12.2021 | Last day of trading in Cessatech’s warrants of series TO 1 is today Tuesday 14 December 2021 | Last day of trading in Cessatech’s warrants of series TO 1 is today Tuesday 14 December 2021 Tue, Dec 14, 2021 08:00 CET
Copenhagen, Denmark, 14 December 2021 – Tuesday, 14 December 2021, is the last day of trading in warrants of series TO ... |
| 08.12.2021 | CEO and Board of Directors have exercised warrants of series TO 1 | CEO and Board of Directors have exercised warrants of series TO 1 Wed, Dec 08, 2021 08:00 CET
Copenhagen, Denmark, 8 December 2021 – The CEO and members of the Board of Directors of Cessatech A/S (“Cessatech” or the “Company”) have exercise... |
| 25.11.2021 | The exercise period for warrants of series TO 1 begins today | Copenhagen, Denmark, 25 November 2021 - Today, 25 November 2021, marks the beginning of the exercise period for the warrants of series TO 1 that were issued in connection with Cessatech A/S ("Cessatech" or the "Company")... |
| 25.11.2021 | The exercise period for warrants of series TO 1 begins today | The exercise period for warrants of series TO 1 begins today Thu, Nov 25, 2021 08:07 CET
Copenhagen, Denmark, 25 November 2021 – Today, 25 November 2021, marks the beginning of the exercise period for the warrants of series TO 1 that were i... |
| 11.10.2021 | The subscription period for Crunchfish rights issue of units begins today | The subscription period for Crunchfish rights issue of units begins today Mon, Oct 11, 2021 08:30 CET
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, HONG KO... |
| 16.09.2021 | Today, the exercise period for warrants in BoMill AB begins | Today, the exercise period for warrants in BoMill AB begins Thu, Sep 16, 2021 08:31 CET
BoMill AB (“BoMill” or “the Company”), an agritech company that is promoting a patented grain sorting solution that allows, in commercial quantities, to... |
| 17.08.2021 | The subscription period in CS MEDICA A/S’s issue of units starts today | The subscription period in CS MEDICA A/S’s issue of units starts today Tue, Aug 17, 2021 08:00 CET
Today, August 17th, 2021, is the first day of the subscription period in CS MEDICA A/S’s (”CS MEDICA” or the ”Company”) issue of units prior ... |
